Does PEA Actually Work for Pain? What the Evidence Shows
PEA has the opposite of the usual credibility problem. Most natural pain ingredients are marketed far ahead of their evidence. Palmitoylethanolamide runs the other way: it has been through more than a dozen randomized controlled trials, yet most people have never heard of it.
So the fair question is not whether PEA is popular. It is whether it actually works. Here is what the controlled human research shows.
Key Takeaways
- PEA (palmitoylethanolamide) is a compound the body makes to help regulate pain and inflammation. We explain how it works in our guide to the endocannabinoid system; this article focuses on whether it works.
- A 2023 meta-analysis of 11 double-blind randomized trials and 774 participants found PEA significantly reduced chronic pain, with a large effect size (SMD 1.68).¹
- A larger 2025 meta-analysis (18 studies, 1,196 patients) reached the same conclusion, strengthening the evidence base.²
- Across roughly 20 trials and about 2,000 patients, micronized PEA showed no serious side effects, even at doses up to 1,200 mg per day.³
What the Clinical Trials Show
For a naturally occurring compound, PEA has a surprisingly solid evidence base. A 2023 systematic review and meta-analysis of double-blind randomized trials pooled 11 studies and 774 participants and found that PEA significantly reduced chronic pain compared with control, with a large effect size (standardized mean difference 1.68, 95% CI 1.05 to 2.31).¹
The signal held as the literature grew. A 2025 meta-analysis extended the pooled data to 18 studies and 1,196 participants and continued to support a role for PEA in pain management.² Two independent meta-analyses, reaching the same conclusion on a growing dataset, is a stronger position than most supplement ingredients can claim.
How Strong Is the Evidence, Really?
Strong enough to take seriously, with honest limits. The effect sizes are meaningful, but trials vary in design, dose, and the type of pain studied, and most of the best data is in persistent, inflammatory, or neuropathic pain rather than a one-off headache. PEA is not a fast rescue painkiller, and it is not a cure.
What the evidence supports is a real, measurable reduction in pain for many people who use it consistently, with an unusually clean safety record behind it. That combination is what makes it worth a place in the conversation.
How PEA Works, in Brief
PEA is an endocannabinoid-like molecule the body produces in stressed or inflamed tissue. It does not block COX enzymes the way ibuprofen does. Instead it activates PPAR-α receptors, calms overactive immune cells such as mast cells and microglia, and supports the body's own cannabinoid-like signaling through what researchers call the "entourage effect."⁵
We break the full mechanism down, including how it fits into the endocannabinoid system, in How the Endocannabinoid System Works and Where PEA Fits In.
PEA and NSAIDs: Different Tools
It is tempting to ask whether PEA is "better" than ibuprofen, but they reduce pain through different mechanisms, and that difference is the point. Ibuprofen blocks the COX enzymes that make prostaglandins, which is fast and effective. It is also why regular NSAID use carries a documented risk to the stomach lining.
| PEA | NSAIDs | |
|---|---|---|
| Primary mechanism | PPAR-α activation; calms immune cells | Inhibits COX-1 and COX-2 enzymes |
| Origin | Produced naturally by the body | Synthetic drug |
| Typical focus | Persistent and inflammatory pain | Acute pain and fever |
| Tolerability in studies | No serious side effects across 20+ trials³ | GI-bleed risk rises with regular use (OR 2.28)⁴ |
None of this makes PEA stronger than an NSAID. It makes it a different tool, which is why it interests people who do not tolerate NSAIDs well, or who would rather not rely on them daily.
Is PEA Safe?
PEA's tolerability is one of its more notable features. A safety review of micronized PEA covering roughly 20 human studies and about 2,000 patients found no serious adverse effects, even at doses as high as 1,200 mg per day.³ As with anything, people who are pregnant, nursing, or taking prescription medication should speak with their clinician before starting something new.
The Bigger Picture
PEA is one of the few naturally derived pain compounds where the evidence is ahead of the hype. It works through the body's own pathways, two meta-analyses support it, and its safety record is reassuring.
It is also rarely the entire answer on its own, which is the reasoning behind combining it. Relivaid pairs palmitoylethanolamide (PEA) with bio-optimized gingerol, a botanical bioactive with extensive traditional and clinical use, and 50 mg of caffeine as a complementary ingredient, in a formula designed for occasional symptoms such as tension headaches, menstrual cramps, inflammation, and muscle or joint aches.*
References
- Lang-Illievich K, et al. Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Nutrients. 2023. doi:10.3390/nu15061350
- Viña I, López-Moreno M. Meta-Analysis of Palmitoylethanolamide in Pain Management. Nutrition Reviews. 2025. doi:10.1093/nutrit/nuae203
- Nestmann ER. Safety of micronized palmitoylethanolamide (microPEA): lack of toxicity and genotoxic potential. Food Science & Nutrition. 2016. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332261/
- Tawfik AG, et al. Nonsteroidal Anti-Inflammatory Drugs and Risk of Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis. Clinical Pharmacology & Therapeutics. 2025. doi:10.1002/cpt.70054
- Di Stefano V, et al. Palmitoylethanolamide: A Multifunctional Molecule for Neuroprotection, Chronic Pain, and Immune Modulation. Biomedicines. 2025. doi:10.3390/biomedicines13061271